BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rakariyatham K, Du Z, Yuan B, Gao Z, Song M, Pan C, Han Y, Wu X, Tang Z, Zhang G, Xiao H. Inhibitory effects of 7,7′-bromo-curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation. European Journal of Pharmacology 2019;858:172479. [DOI: 10.1016/j.ejphar.2019.172479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Costa SOAM, Rodrigues IB, Braga AV, Barbosa BCM, Silva RRL, Rodrigues FF, Melo ISF, Morais MÍ, Castro BFM, Júnior ASC, Maltarollo VG, Oliveira RB, Coelho MM, Machado RR. RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in mice. Inflammopharmacol. [DOI: 10.1007/s10787-021-00913-9] [Reference Citation Analysis]
2 Wu X, Li Z, Sun Y, Li F, Gao Z, Zheng J, Xiao H. Identification of Xanthomicrol as a Major Metabolite of 5-Demethyltangeretin in Mouse Gastrointestinal Tract and Its Inhibitory Effects on Colon Cancer Cells. Front Nutr 2020;7:103. [PMID: 32850933 DOI: 10.3389/fnut.2020.00103] [Reference Citation Analysis]
3 Jiang T, Liao W, Charcosset C. Recent advances in encapsulation of curcumin in nanoemulsions: A review of encapsulation technologies, bioaccessibility and applications. Food Res Int 2020;132:109035. [PMID: 32331634 DOI: 10.1016/j.foodres.2020.109035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 21.0] [Reference Citation Analysis]